<DOC>
	<DOC>NCT01813305</DOC>
	<brief_summary>The objective of this study is to evaluate the efficacy and safety of CSTC1 in patient with diabetic foot ulcers.</brief_summary>
	<brief_title>CSTC1 for Diabetic Foot Ulcers Phase II Study</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>With either gender aged at least 20 years old; With a diabetic ulcer (which is defined as the target ulcer) on the foot and not healing for at least 2 weeks; The target ulcer is classified as grade 1 or 2 ulcer according to modified Wagner system; The target ulcer should show "infection control" at investigator's discretion; Subject should be free of any necrosis or infection in soft and bone tissue; Subject has signed the written informed consent form With active osteomyelitis; With target ulcer size decreased by at least 50% after at least 2 weeks of standardofcareonly period or any other recorded regular therapy before Randomization visit; With poor nutritional status (albumin &lt; 3g/dl), poor diabetic control (HbA1c &gt; 12%), anemia (hemoglobin&lt;10 g/dL), a leukocyte counts &lt; 1,000/mm3, abnormal liver function (AST, ALT&gt;3 x upper limit of normal range); Requiring treatment with corticosteroids, immunosuppressive or chemotherapeutic agents; Presence of necrosis, purulence or sinus tracts that cannot be removed by debridement; Receiving revascularization surgery performed &lt;8 weeks before entry in the study; With known or suspected hypersensitivity to any ingredients of study product and vehicle; With coronary heart disease with myocardial infarction, coronary artery bypass graft (CABG), or percutaneous transluminal coronary angioplasty (PTCA) within 3 months prior to study; Pregnant or lactating or premenopausal with childbearing potential but not taking reliable contraceptive method(s) during the study period; Enrollment in any investigational drug trial within 4 weeks before entering this study; With any uncontrolled illness judged by the investigator that entering the trial may be detrimental to the subject.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Diabetic Foot Ulcer</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Debridement</keyword>
	<keyword>Standard of Care</keyword>
	<keyword>wounds</keyword>
</DOC>